Drug Concentration Profiles
Drug Concentration Profiles - Related Videos
01:23
Drug Concentrations: Measurements
0 Views •
2024
Drug concentration is the quantity of a drug present in a biological sample. Measuring drug amounts in biological samples allows the clinician to understand how a drug is absorbed, distributed, metabolized, and excreted. Samples can be obtained through invasive or non-invasive methods. Invasive techniques involve surgical or parenteral interventions to gather blood, cerebrospinal fluid, or tissue biopsy. Conversely, non-invasive approaches provide samples like urine, feces, and saliva. Plasma —...
01:15
Drug Concentration Versus Time Correlation
0 Views •
2024
The plasma drug concentration-time curve is a crucial tool in pharmacokinetics, representing the drug's concentration in plasma at different time intervals post-administration. This curve illustrates the drug's journey from absorption into the systemic circulation, distribution to body tissues, and eventual elimination through excretion or biotransformation. Two pivotal parameters are the minimum effective concentration (MEC) and the minimum toxic concentration (MTC). The MEC is the lowest drug...
01:18
Pharmacodynamic Models: Emax Drug–Concentration Effect Model
0 Views •
2026
The Emax drug-concentration effect model is central to pharmacodynamics in drug discovery and development. This model is predicated on the receptor occupancy theory, which posits that the effect of a drug is directly related to the number of receptors occupied by the drug and the resultant complex formation.The model describes the reversible interaction between a drug (C) and a receptor (R) to form a drug-receptor complex (RC). The kinetics of this interaction are quantified by an equation that...
14:11
Quantification of Hydrogen Concentrations in Surface and Interface Layers and Bulk Materials through Depth Profiling with Nuclear Reaction Analysis
0 Views •
Cited by 21 •
2016
We illustrate the application of 1H(15N,αγ)12C resonant nuclear reaction analysis (NRA) to quantitatively evaluate the density of hydrogen atoms on the surface, in the volume, and at an interfacial layer of solid materials. The near-surface hydrogen depth profiling of a Pd(110) single crystal and of SiO2/Si(100) stacks is described.
01:14
Drug Dissolution: Requirements and Profile Comparison
0 Views •
2025
The acceptance criteria for dissolution profile data are anchored in Q values, representing the percentage of drug dissolved within a specified period. This assessment unfolds in three stages:First Stage: The test passes if all six drug dosage units are equal to or greater than Q plus 5%; otherwise, the sample proceeds to the second stage.Second Stage: The average of twelve units must be equal to or greater than Q, with no unit falling below Q - 15% to pass; if not, it progresses to the final...
FAQs
These processes create the changing phases of drug exposure after administration. Absorption raises concentration as the drug enters the body, distribution alters where it is present, and metabolism and excretion reduce the amount available over time. Their combined effects determine the profile’s shape, helping clinicians relate concentration changes to treatment response and potential toxicity.
A higher dose can increase peak concentration and overall exposure, whereas the dosing interval influences how frequently concentrations rise and fall. The administration route affects how the drug enters the body, while clearance determines how quickly it is removed. Considering these variables together supports dose selection and helps explain differences between treatment regimens.
Peak concentration indicates the highest measured level, while time to peak shows when that level occurs after administration. Overall exposure summarizes the concentration pattern across time. Examining all three prevents reliance on a single measurement: peak-related findings can differ from exposure-related findings, which is important when assessing efficacy, toxicity, or formulation performance.
Profiles allow researchers to compare how formulations produce concentration changes after administration. Differences in peak concentration, time to peak, or overall exposure may indicate that formulations behave differently in the body. Such comparisons support formulation evaluation and can contribute to bioequivalence assessments when investigators need to determine whether products provide sufficiently comparable exposure patterns.
In therapeutic drug monitoring, concentration information is interpreted alongside the patient’s treatment regimen and clinical needs. The resulting profile can help assess whether exposure is consistent with the intended treatment and whether dose selection may require adjustment. This application is particularly relevant when clinicians must balance expected efficacy against the possibility of toxicity.
Profiles provide a pharmacokinetic basis for adapting treatment regimens to concentration-related goals. By considering dose, route, dosing interval, peak concentration, and overall exposure, clinicians and researchers can evaluate how a regimen may influence response or toxicity. This supports safer, more individualized approaches rather than relying solely on a uniform dosing plan.